メニュー
JP | JPY
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
JP | JPY
GMP info
Regarding suitability of Eppendorf bioprocess equipment in GMP-regulated applications, please reach out to your Eppendorf sales representative.
Bioprocessing in Vaccine Development
At Eppendorf, our aim is to empower your upstream bioprocessing in vaccine development. We provide tools that help you accelerate process development by working in parallel, increasing turn-around time, and leveraging the full potential of bioprocess data. We support you in increasing cost-efficiency by intensifying bioprocesses and streamlining scale-up. You discover new ways for vaccine production. We deliver solutions to help bringing your bioprocess to the next level. So come and talk to us, we’re all ears.
もっと読む
表示を減らす
Our bioprocess solutions for vaccine development
We are not about one-size-fits-all solutions – instead we focus on empowering your business with tailored bioprocess solutions.
もっと読む
表示を減らす
Scalable bioprocess systems
Since vaccine development is a challenging and complex process, it's essential to carefully prepare your approach to if possible avoid potential issues. Crucial aspects to consider is how to optimize your process at small scale and how you will scale up your cell culture from the lab to pilot and industrial scales. Eppendorf offers a wide range of bioreactors from 60 mL to 2400 L to suit the needs from research to pilot production scale.
もっと読む
表示を減らす
The Eppendorf range of bioreactor systems:
- Small-scale: DASbox® Mini Bioreactor System and DASGIP® Parallel Bioreactor Systems
- Bench-scale:SciVario® twin, BioFlo® 120, BioFlo® 320
- Pilot/production-scale: BioFlo® 720, BioFlo® 510/CelliGen 510, BioFlo® 610, BioFlo® Pro
Single-use bioreactors
The use of single-use bioreactors increases turn-around, eliminates the need for bioreactor cleaning, and decreases the risk of cross-contamination. Eppendorf offers a large portfolio of single-use bioreactors for use in vaccine development. Regardless of the cells you employ to make vaccines, there are single-use bioreactors created specifically for your needs, for example:
- Microbial cells: BioBLU® f Single-Use Bioreactors (65 mL to 3.75 L)
- Cell Culture: BioBLU® c and p Single-Use Bioreactors (100 mL to 40 L)
- Cell Culture: BioFlo® 720 control station compatible with Thermo Scientific® HyPerforma® Single-Use Bioreactors (50 L to 500 L)
Cell culture in perfusion
In perfusion mode, cells are retained inside the bioreactor while the medium is constantly exchanged. Like this the cell medium compositions remains more stable during the process which potentially favours a more consistent product quality. This means that toxic by-products need to be removed while the cells are retained in the bioreactor. The retention method varies depending on whether the cell line can be grown in suspension or needs to adhere to a growth matrix.
Eppendorf offers solutions for upstream bioprocessing in perfusion:
Find more information about these cell retention technologies and how to use them with the Eppendorf bioreactor systems
Eppendorf offers solutions for upstream bioprocessing in perfusion:
- Bioreactor systems connectable to filtration devices for cell retention
- Bioreactor systems connectable to Cell-Lift impeller and decanter column
- Packed-bed bioreactors filled with Fibra-Cel® Disks
Find more information about these cell retention technologies and how to use them with the Eppendorf bioreactor systems
もっと読む
表示を減らす
Cultivation of adherent cells
Some cell types used in vaccine development, including Vero cells, are anchorage-dependent cells requiring a growth matrix to adhere to in order to be cultivated in stirred-tank bioreactors. There are two main approaches to ensure these cell types are retained correctly:
- Microcarriers: beads in suspension to which adherent cells can attach and grow in bioreactors
- Packed-bed bioreactors: bioreactors with a fixed bed of Fibra-Cel® Disks on which the cells are immobilized
Find out more about the cultivation of anchorage-dependent cells in Eppendorf bioreactors!
The value of bioreactors in vaccine development
Vaccines are critical to both human and animal health. They are becoming an ever more vital tool in the fight against current and future diseases. To meet the growing global demand for new vaccines, it is important to be able to produce them in an efficient and cost-effective manner. Find out, how cell culture in bioreactors offers a standardized, scalable, and cost-effective way for developing vaccines and how our bioprocess solutions can support you with your specific challenge.
もっと読む
表示を減らす
Webinar: Stirred tank bioreactors in vaccine development
The use of cell culture in bioreactors offers a standardized, scalable, and cost-effective procedure for developing vaccines. Learn, how suspension cells were efficiently cultivated in bioreactors to produce AAV particles and COVID-19 spike-proteins in suspension culture.
Process development
The purpose of upstream bioprocess development is to reduce the overall manufacturing cost of vaccine development while maximizing the quantity and quality of the desired final product. Various cultivation parameters, such as the temperature, pH , DO , shear force, and nutrient supply can affect cell growth and protein expression levels. Thus, it is essential to evaluate each of these conditions and their interactions to determine the most effective conditions for your bioprocess.
もっと読む
表示を減らす
Learn more about how the Eppendorf solutions help you saving time in bioprocess development.
もっと読む
表示を減らす
Bioprocess scale-up
Bioprocess insight gained at small-scale can help to ensure a high level of success in your large-scale processes. Once the ideal conditions have been achieved, bioreactors can be used to effectively scale-up your culture from benchtop to pilot and industrial scales. Several scale-up strategies exist to ensure maximum efficiency and product quality is maintained.
もっと読む
表示を減らす
Learn more about scale-up strategies and how the Eppendorf bioprocess equipment can help streamlining scale-up.
もっと読む
表示を減らす
Process intensification
Process intensification, a methodology for reducing equipment, energy consumption, and waste generation while achieving higher quality products, can make a substantial contribution to further increasing process productivity and lowering production costs. One way to optimize your bioprocessing is fine-tuning the control of your bioprocess through Process Analytic Technology (PAT) which can help to improve reproducibility, reduce batch-to-batch variation, and increase yields and product quality. Another important consideration when intensifying the rate or increasing the yield is which operation mode to use for your bioprocess. A variety of strategies including batch, fed-batch, and continuous cultures exist to help you optimize batch quality and yield.
もっと読む
表示を減らす
Learn more about how to reduce batch-to-batch variability and increase yield.
もっと読む
表示を減らす
How our customers use our products
The real experts are our customers. Meet some of them and find out what their work is all about.
もっと読む
表示を減らす
A selection of our customers
Read more about the different vaccine types
Vaccines come in a wide variety of forms, including:
- Live attenuated vaccines that use a weakened (attenuated) version of the pathogen e.g., the measles, mumps, rubella (MMR) vaccine
- Inactivated vaccines that use an altered or killed version of the pathogen that cannot replicate e.g., rabies vaccine
- Subunit vaccines and toxoid vaccines that use protein, polysaccharide, or the pathogen capside.g., hepatitis B vaccine
- DNA and RNA vaccines that use DNA or RNA that codes for antigens from the pathogen, e.g., some COVID-19 vaccines
もっと読む
表示を減らす
Watch this in-depth video for all the essential information about viruses, vaccinations, and vaccine development.
もっと読む
表示を減らす
Read about the advantages of bioreactors for vaccine production
Once research has shown the ideal candidate antigen for a specific vaccine development plan, it is crucial to find the means to produce this antigen at sufficiently high quantities to meet the growing global demands for new vaccines. In this phase, either the pathogen itself is produced, with additional steps for later inactivation or isolation of a subunit, or a recombinant protein derived from the pathogen. The use of cell culture in bioreactors offers a standardized, scalable, and cost-effective procedure for developing vaccines.
もっと読む
表示を減らす
To meet growing global demands for new vaccines, it’s important to be able to produce vaccines in an efficient and cost-effective manner. This is especially true for diseases with a high mutation rate and transmissibility. One method for vaccine production is the use of embryonated chicken eggs (ECE), which have limitations in terms of the availability of high-quality and specific pathogen-free (SPF) eggs, scalability, and potential health concerns including egg allergies.
もっと読む
表示を減らす
The use of cell culture systems offers a more scalable procedure for developing vaccines. Advances in bioprocessing mean that it is now possible to grow mammalian and microbial cells to high densities in bioreactors, allowing for the large-scale production of a variety of viral vectors, live attenuated vaccines, and several subtypes of vaccines. Bioreactors combine an optimizable environment with scalability, and a more standardized and automated process for vaccine development.
もっと読む
表示を減らす
Discover more advantages of vaccine development using mammalian cells
White Paper
PDF 0.3 MB
Get to know more about approaches and trends in vaccine development production
Infographic: Vaccine development workflow
The vaccine development journey involves several stages, from selecting lead candidates to process development, and manufacturing. Gain a better understanding of the vaccine development workflow, and learn about the problems and potential solutions of each stage.
ebook: Challenges in upstream bioprocessing
Vaccine manufacturers are facing the challenge of developing new products to serve unmet needs and fulfill the demands in an economically viable way. Read expert views and case studies on some of the hot topics in vaccine bioprocess development.
ebook: Cultivation of adherent and suspension cells
Discover application examples for the cultivation of adherent and suspension cells for vaccine development.
Panel discussion: Trends in vaccine development
Check out this video of experts discussing trends in vaccine development including automation.
